This site is intended for healthcare professionals only
LoginRegister
Jubilant Pharmova to sell API business to wholly owned armDrugs in CDSCO samples Counterfeit, not ours, say leading pharma companies
USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facilityUSFDA issues three observations each on API, Finished Product side of Lupin Pithampur facility
Novartis, Arrowhead strike upto USD 2 billion deal for neuromuscular therapy licenseLupin arm ink pact with Celnova for distribution of Orphan Drug NaMuscla in Argentina, Colombia
Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMAPresent difference of approved and proposed formulation: CDSCO tells Novo Nordisk's Semaglutide...
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanAlembic Pharma receives USFDA approval for schizophrenia drug Paliperidone Extended Release
Sun Pharma Halol facility gets OAI status from USFDASun Pharma presents new clinical efficacy, safety data in severe dermatological conditions at 2024...
Wockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW summit in DubaiWockhardt group Founder Chairman Dr Habil Khorakiwala bags Lifetime Achievement Award at 10th IHW...
OPPI appoints Bhushan Akshikar as PresidentOPPI appoints Bhushan Akshikar as President
Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in ExpansionBiocon partners with Tabuk Pharma to commercialize GLP -1 products in Middle East region
PfizerConduct Active Surveillance Study: CDSCO Panel Tells Pfizer on Abrocitinib tablets
CDSCO Flags 8 batches of Spurious Medicines, Including Popular Brands Augmentin, PAN 405 formulations declared as spurious including Sun Pharma's Ursocol 300, Glenmark's Telma H
Dr Reddys Labs API Mirfield facility gets 7 USFDA observationsMexican drug regulator imposes Rs 28 lakh penalty on Dr Reddy's Labs
X